Perfuze is a medical device company developing catheter-based aspiration technology to treat acute ischemic stroke.
Perfuze has raised $23.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in March 2025.
Perfuze's investors include Enterprise Ireland, SV Health Investors, EQT Life Sciences, Seroba Life Sciences, EarlyBird.
Perfuze is headquartered in Newcastle, Ireland.
Perfuze is a medical device company developing catheter-based aspiration technology to treat acute ischemic stroke.
Perfuze is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Perfuze — Funding & Investors." VCBacked, March 13, 2025, https://www.vcbacked.co/company/perfuze. Accessed July 19, 2026.
VCBacked. (2025). Perfuze — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/perfuze
{{cite web |title=Perfuze — Funding & Investors |url=https://www.vcbacked.co/company/perfuze |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated